Levitas Pharmaceuticals Private Limited, a active private limited company, was established on 09 April 2013 in Ernakulam, Kerala, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230KL2013PTC033766. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.98 M.
Formerly known as Zeus Fashions Private Limited. It upholds a compliant status. Employing 2 professional, Its leadership includes Shinu (Director), Jino Paul (Director), Kalayil Varghese Siji (Managing Director). Past directors included Manoj Mathew, Muhammed Musthafa, Chris Francis. It holds ₹2.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2018, with the balance sheet filed on 31 March 2018. It is based at 49/1251A, Ground Floor, Kaithakkal Building Nr.Dawson Vihar, Thykoodam, Vyttila, Ernakulam, Kerala, 682019.
U24230KL2013PTC033766
033766
09 April 2013
₹1.00 M
₹0.98 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Levitas Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shinu | Director | 27 Jun 2019 | Current |
| Jino Paul | Director | 24 Mar 2022 | Current |
| Kalayil Varghese Siji | Managing Director | 29 Oct 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Jun 2019 | Past |
| Pramod Abcsdd | Director | 27 Sep 2017 | Past |
| Pramod Abcsdd | Director | 29 Oct 2015 | Past |
| Pramod Abcsdd | Director | 09 Mar 2016 | Past |
| Pramod Abcsdd | Director | 29 Oct 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Levitas Pharmaceuticals Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 13.95% increase. The company also saw a substantial improvement in profitability, with a 249.68% increase in profit. The company's net worth Soared by an impressive increase of 122.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Levitas Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Nov 2018 | Others | ₹2.50 M | Open |
Explore comprehensive loan charge details -
Levitas Pharmaceuticals has a workforce of 2 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Levitas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Levitas Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jino Paul was appointed as a Director was appointed as a Director on 24 Mar 2022 & has been associated with this company since 3 years 8 months . was recorded as a recent event.
Shinu was appointed as a Director was appointed as a Director on 27 Jun 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 2.50 M with Charge ID 100217247 was registered on 23 Nov 2018. was documented.
Progress on Levitas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records. was documented.
Progress on Levitas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Ernakulam. was documented.
Kalayil Varghese Siji was appointed as a Managing Director was appointed as a Managing Director on 29 Oct 2015 & has been associated with this company since 10 years 1 month . was recorded as a recent event.
The CIN of Levitas Pharmaceuticals Private Limited is U24230KL2013PTC033766.
Levitas Pharmaceuticals Private Limited is headquartered at 49/1251A, Ground Floor, Kaithakkal Building Nr.Dawson Vihar, Thykoodam, Vyttila, Ernakulam, Kerala, 682019.
Levitas Pharmaceuticals Private Limited was incorporated on 09 April 2013.
The current directors of Levitas Pharmaceuticals Private Limited are
The primary industry of Levitas Pharmaceuticals Private Limited is Trade.
Levitas Pharmaceuticals Private Limited is unlisted.
The authorized capital of Levitas Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.98 M.
The compliance status of Levitas Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX